{"id":236402,"date":"2026-09-09T10:59:27","date_gmt":"2026-09-09T05:29:27","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=236402"},"modified":"2026-09-09T10:59:27","modified_gmt":"2026-09-09T05:29:27","slug":"why-glenmark-pharmaceuticals-share-price-fall-today-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-glenmark-pharmaceuticals-share-price-fall-today-2026\/","title":{"rendered":"Glenmark Pharmaceuticals (GLENMARK) Share Price Falls 2.56% Today"},"content":{"rendered":"
Glenmark Pharmaceuticals (GLENMARK)<\/a>share price fell to Rs 2,414 today, down 2.56% from the previous close. Market cap was Rs 69,483.71 crore.<\/em><\/div>\n

Glenmark Pharmaceuticals Share Price fell to Rs 2,414 on 09 September 2026 at 10:53:16 AM IST, down 2.56% or Rs 63.35 for the session so far. The company remained in the Large Cap category, with a market capitalisation of Rs 69,483.71 crore. The session also showed a notable intraday reversal: the stock opened at Rs 2,486.9, which was also the day\u2019s high, and later moved down to a low of Rs 2,403.1.<\/p>\n

The supplied market data confirms the decline but does not identify a company-specific trigger. Even without a stated catalyst, the move is relevant because Glenmark is a sizeable healthcare name in the Pharmaceuticals & Drugs industry. That means today\u2019s weakness is best assessed not only through price action, but also through valuation, profitability and peer positioning within the listed pharma space.<\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n